Immunovant, Inc. (IMVT)
32.04
-0.07
(-0.22%)
USD |
NASDAQ |
Oct 07, 16:00
32.06
+0.02
(+0.06%)
After-Hours: 20:00
Immunovant EPS Diluted (Quarterly) : -0.7454 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7454 |
| March 31, 2026 | -0.7258 |
| December 31, 2025 | -0.6095 |
| September 30, 2025 | -0.7285 |
| June 30, 2025 | -0.7059 |
| March 31, 2025 | -0.6384 |
| December 31, 2024 | -0.7563 |
| September 30, 2024 | -0.745 |
| June 30, 2024 | -0.5966 |
| March 31, 2024 | -0.5182 |
| December 31, 2023 | -0.3558 |
| September 30, 2023 | -0.4473 |
| June 30, 2023 | -0.5666 |
| March 31, 2023 | -0.4585 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.4918 |
| September 30, 2022 | -0.4111 |
| June 30, 2022 | -0.3464 |
| March 31, 2022 | -0.4055 |
| December 31, 2021 | -0.3598 |
| September 30, 2021 | -0.3456 |
| June 30, 2021 | -0.311 |
| March 31, 2021 | -0.2874 |
| December 31, 2020 | -0.3245 |
| September 30, 2020 | -0.2464 |
| June 30, 2020 | -0.3771 |
| March 31, 2020 | -0.376 |
| December 31, 2019 | -0.2753 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roivant Sciences Ltd. | -0.2634 |
| Moderna, Inc. | -1.965 |
| Altimmune, Inc. | -0.1231 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| First Tracks Biotherapeutics, Inc. | -0.943 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -153.22M |
| Total Expenses (Quarterly) | 153.22M |
| Enterprise Value | 5.811B |
| Earnings Yield | -8.77% |
| Normalized Earnings Yield | -8.768 |